Core Points - The article outlines the management system for the resignation of directors and senior management at Liaoning Chengda Co., Ltd, aiming to ensure stability in corporate governance and protect the rights of shareholders [1][2]. Group 1: General Principles - The resignation management system is based on principles of legality, transparency, smooth transition, and protection of shareholder rights [1]. - The system applies to various resignation scenarios, including term expiration, voluntary resignation, dismissal, or other reasons [1]. Group 2: Resignation Procedures - Directors and senior management can resign before their term ends by submitting a written report, with the resignation effective upon receipt by the board [2]. - The company must complete the re-election of directors within 60 days if a resignation occurs, ensuring compliance with legal and regulatory requirements [2]. Group 3: Responsibilities and Obligations - Resigning directors and senior management must complete handover procedures and remain liable for their duties for six months post-resignation [4]. - They are required to maintain confidentiality regarding company secrets even after leaving [4]. Group 4: Shareholding Management - Directors and senior management are restricted from transferring 25% of their shares for six months after resignation, with exceptions for legal circumstances [5]. - Any commitments made regarding shareholding must be strictly adhered to by the resigning individuals [5]. Group 5: Accountability Mechanism - The company reserves the right to seek compensation from resigning directors and senior management for any losses incurred due to violations of laws or commitments [5]. - If any breaches of duty or unfulfilled commitments are discovered, the board will take necessary actions to hold individuals accountable [5]. Group 6: Miscellaneous - The system will be executed in accordance with relevant national laws and regulations, and the board is responsible for its interpretation and amendments [6].

Core Viewpoint - The report highlights the financial performance and operational challenges faced by Liaoning Cheng Da Co., Ltd. during the first half of 2025, with a focus on its four main business segments: pharmaceutical and medical, financial investment, domestic and international trade, and energy development. Financial Performance - The company reported a total revenue of 5.35 billion yuan, a decrease of 0.83% compared to the same period last year [5][6] - Total profit reached 816.12 million yuan, marking a significant increase of 65.64% year-on-year [5][6] - Net profit attributable to shareholders was 717.57 million yuan, up 56.18% from the previous year [5][6] - The company's net assets increased by 2.56% to 30.05 billion yuan, while total assets rose by 2.44% to 49.00 billion yuan [5][6] Business Segments Overview Pharmaceutical and Medical - The pharmaceutical segment, primarily through Cheng Da Biological, faced intense competition in the human vaccine market, leading to a revenue decline of 19.74% to 707 million yuan [6][7] - Cheng Da Biological maintains a leading position in the rabies vaccine market, with ongoing development of various vaccine products [6][10] Financial Investment - The financial investment segment saw significant growth, with investment income from Guangfa Securities increasing by 53.19% to 1.08 billion yuan [6][7] - The insurance sector also performed well, with China United Insurance's investment income rising by 143.94% [6][7] Domestic and International Trade - The trade segment achieved a revenue of 4.63 billion yuan, a growth of 3.20%, driven by strong performance in textile and apparel exports [6][7] - The company focused on risk management and operational stability amid fluctuating commodity prices [6][7] Energy Development - The energy segment reported a revenue of 133,000 yuan, with a net loss of 329 million yuan due to extended production halts and regulatory challenges [6][7] - The company is working on obtaining necessary permits for mining operations to resume production [6][7] Market Conditions - The overall economic environment is characterized by slow growth and increased uncertainty, with domestic demand remaining insufficient [6][7] - The pharmaceutical industry is under pressure due to increased competition and declining vaccination rates among the population [6][7] - The financial services sector is expected to continue benefiting from China's economic development and reforms [6][7]

Core Viewpoint - The financial performance of Liaoning Chengda Co., Ltd. shows a significant increase in net profit and total profit for the first half of 2025, despite a slight decrease in revenue compared to the previous year [1][2]. Financial Summary - Total assets at the end of the reporting period reached approximately 49.00 billion RMB, an increase of 2.44% from the previous year [1]. - Net assets attributable to shareholders increased to approximately 30.05 billion RMB, reflecting a growth of 2.56% year-on-year [1]. - Operating revenue for the period was approximately 5.35 billion RMB, down by 0.83% compared to the same period last year [1]. - Total profit for the period was approximately 816.12 million RMB, representing a substantial increase of 65.64% year-on-year [1]. - Net profit attributable to shareholders was approximately 717.57 million RMB, up by 56.18% compared to the previous year [1]. - The net profit after deducting non-recurring gains and losses was not specified [1]. - The net cash flow from operating activities was approximately -139.97 million RMB, showing an improvement from -155.57 million RMB in the previous year [1]. - The weighted average return on equity increased to 2.42%, up by 0.85 percentage points from the previous year [1]. - Basic and diluted earnings per share were both 0.4714 RMB, an increase of 56.20% year-on-year [1]. Shareholder Information - The total number of shareholders at the end of the reporting period was 66,011 [1]. - The largest shareholder, Shaoguan Gaoteng Enterprise Management Co., Ltd., holds 16.20% of the shares, with a total of approximately 247.77 million shares [2]. - Other significant shareholders include Guangxi Xinyi Xin Business Service Co., Ltd. with 8.52% and Jilin Aodong Pharmaceutical Group Co., Ltd. with 6.75% [2]. Debt Financing - The company has issued various debt instruments, including corporate bonds and short-term financing bonds, with interest rates ranging from 2.50% to 5.70% [3]. - The debt-to-asset ratio at the end of the reporting period was 32.61%, slightly up from 32.31% at the end of the previous year [3]. - The EBITDA interest coverage ratio improved to 4.04 from 2.98 in the previous year [3].

General Overview - The document outlines the major event reporting system of Liaoning Chengda Co., Ltd, aiming to standardize the management of significant events and ensure timely, accurate, and comprehensive information disclosure [1][2]. Reporting Obligations - The reporting obligations apply to various company personnel, including directors, senior management, and those in charge of subsidiaries, who must report significant events to the board secretary and chairman [1][2][3]. - The board secretary is responsible for organizing and coordinating the company's information disclosure affairs and is the main person for summarizing internal reports of significant information [2][3]. Scope of Major Events - Major events include significant transactions, related party transactions, major lawsuits, performance forecasts, stock price fluctuations, and any events that may pose significant risks to the company [3][4]. - Specific reporting criteria include transactions exceeding 10% of the company's value or significant lawsuits exceeding 10 million yuan [3][4]. Internal Reporting Procedures - Personnel with reporting obligations must notify the board secretary on the same day they become aware of significant events, using various communication methods [5][6]. - The board secretary must analyze and determine which matters require board or shareholder meeting review and ensure compliance with relevant laws and regulations [6][7]. Responsibilities and Penalties - All departments and subsidiaries must adhere strictly to the reporting system, with penalties for failing to report significant events, including criticism, warnings, economic penalties, or even legal responsibility [8][9]. - Information must not be disclosed externally before it is officially released, and any unauthorized disclosure is prohibited [8][9].

Core Points - The article outlines the investor relations management system of Liaoning Chengda Co., Ltd, emphasizing the importance of communication between the company and its investors to enhance corporate governance and protect investor rights [1][2][3] Group 1: Objectives of Investor Relations Management - The primary goals include fostering a positive relationship with investors, establishing a stable investor base, creating a culture that respects and serves investors, maximizing overall company benefits, and increasing transparency in information disclosure [2][3][4] Group 2: Principles of Investor Relations Management - The management system is based on principles such as compliance with laws, equal treatment of all investors, proactive engagement with investors, and maintaining honesty and integrity in communications [3][4][5] Group 3: Communication Channels and Methods - The company is required to utilize multiple channels for investor communication, including its official website, new media platforms, and various forms of meetings and events to facilitate investor engagement [8][9][10] Group 4: Responsibilities and Organization - The board secretary is designated as responsible for investor relations management, supported by the board office, and the company may hire professional agencies to assist in these efforts [26][27][29] Group 5: Handling Investor Complaints and Feedback - The company must establish a robust mechanism for addressing investor complaints and feedback, ensuring timely and appropriate responses to investor inquiries [16][17][18]

Core Points - The company has established a compensation management system for its directors and senior management to enhance work motivation and improve operational efficiency [1][2] - The compensation system is applicable to directors, the president, vice presidents, the financial director, the board secretary, and other senior management recognized by the president [1] - The compensation principles include alignment with company size and performance, job value, sustainable development goals, and performance assessment results [1][2] Compensation Structure - The annual compensation for internal directors and senior management consists of basic salary, performance salary, and other incentives [2] - Basic salary is determined based on position value, responsibilities, capabilities, and market salary trends [2] - Performance salary is linked to company market value management, core operational goals, annual strategic priorities, and individual performance assessments [2] Board and Committee Responsibilities - The Compensation and Assessment Committee is responsible for proposing compensation plans for directors and senior management, which require board approval and shareholder meeting ratification [1][2] - External directors receive a fixed allowance of 100,000 yuan per year (pre-tax), while independent directors receive 160,000 yuan per year (pre-tax) [2] - The company covers travel expenses for external and independent directors related to board and shareholder meetings [2] Implementation and Compliance - The compensation management system becomes effective after approval by the board and shareholders, with any amendments following the same process [2] - The board is responsible for interpreting the compensation management system [3]

目 录 第一章 总 则 第五章 内部存、贷款管理 第二章 筹资管理 第六章 资金计划管理 第三章 资金账户管理 第七章 理财及其他资金业务管理 第四章 货币资金集中收付管理 第八章 附 则 辽宁成大股份有限公司 货币资金管理制度 （2025 年修订） 第一条 为了促进辽宁成大股份有限公司（以下简称"公司"）提高资金使 用效益，防范和控制资金风险，保障资金安全，根据国家相关法律法规、《企业 内部控制基本规范》和《企业内部控制应用指引第 6 号—资金活动》，结合公司 实际，制订本制度。 第一章 总 则 第二条 本制度适用于公司直接或间接持股的全资子公司、控股子公司以及 纳入公司合并财务报表的其他主体（以下简称"子公司"），但不包括公司控股的 上市公司及非上市公众公司。公司控股的上市公司及非上市公众公司的资金管理 业务应根据中国证券监督管理委员会、证券交易所及全国中小企业股份转让系统 有限责任公司的相关规定，自行独立管理。 第三条 本制度所称的货币资金是指公司拥有或可支配的现金、银行存款和 其他货币资金等。本制度的货币资金管理包含筹资、资金集中与收付、资金账户 等与资金活动相关的管理。货币资金管理至少须防范以下风险 ...

辽宁成大股份有限公司 关联交易管理制度 第一章 总则 第一条 为规范辽宁成大股份有限公司（以下简称"公司"）的关联交易行 为，提高公司规范运作水平，保护公司和全体股东的合法权益，根据《中华人民 共和国公司法》《中华人民共和国证券法》（以下简称"《证券法》"）、《上 海证券交易所股票上市规则》（以下简称"《上市规则》"）、《上海证券交易 所上市公司自律监管指引第5号——交易与关联交易》等有关法律法规、规范性 文件及《辽宁成大股份有限公司章程》（以下简称"《公司章程》"）的有关规 定，制定本制度。 第二条 公司的关联交易应当遵循以下基本原则： （一）符合诚实信用的原则； （二）具有合法性、必要性、合理性，定价公允； （三）公司进行关联交易应当签订书面协议，遵循平等自愿、等价有偿的原 则，协议内容应明确、具体； （四）关联交易程序应当符合相关法律法规的规定。 第二章 关联人及关联交易的认定 第三条 公司的关联人包括关联法人（或者其他组织）和关联自然人。 具有以下情形之一的法人（或者其他组织），为公司的关联法人（或者其他 组织）： （一）直接或者间接控制公司的法人（或者其他组织）； （二）由前项所述法人（或者其他组织 ...

General Provisions - The company establishes a system for the temporary suspension and exemption of information disclosure to ensure compliance with legal obligations and internal regulations [1][2] - The company must disclose information truthfully, accurately, completely, timely, and fairly, avoiding misuse of suspension or exemption to mislead investors [2][3] Scope and Conditions for Suspension and Exemption - The company should carefully determine the scope of information that can be temporarily suspended or exempted from disclosure, maintaining consistency with the initial listing conditions [4][5] - Information involving state secrets can be exempted from disclosure if there is sufficient evidence proving that disclosure would violate confidentiality regulations [5][6] - Business secrets can be temporarily suspended or exempted from disclosure if they fall under specific conditions that could lead to unfair competition or harm to the company or others [6][7] Internal Procedures and Reporting - The company must follow an internal approval process for any temporary suspension or exemption of disclosure, which includes documentation and archiving for ten years [5][6] - The company is required to report any temporary suspension or exemption of disclosure to the relevant regulatory bodies within ten days after the announcement of periodic reports [6][7] Additional Provisions - The company must revise the system as necessary to align with national laws and regulations, ensuring that any conflicts are resolved according to legal standards [8][9] - The board of directors is responsible for interpreting the system and ensuring its effective implementation [8]

第五条 公司控股股东、实际控制人及其他关联人不得占用公司募集资金， 不得利用公司募集资金投资项目（以下简称"募投项目"）获取不正当利益。 公司发现控股股东、实际控制人及其他关联人占用募集资金的，应当及时要 求归还，并披露占用发生的原因、对公司的影响、清偿整改方案及整改进展情况。 第三条 公司募集资金应当专款专用。公司使用募集资金应当符合国家产业 政策和相关法律法规，践行可持续发展理念，履行社会责任，原则上应当用于主 营业务，有利于增强公司竞争能力和创新能力。 第四条 公司董事会应当持续关注募集资金存放、管理和使用情况，有效防 范投资风险，提高募集资金使用效益。 公司的董事和高级管理人员应当勤勉尽责，确保维护公司募集资金安全，不 得操控公司擅自或变相改变募集资金用途。 辽宁成大股份有限公司 募集资金管理制度 第一章 总 则 第一条 为规范辽宁成大股份有限公司（以下简称"公司"）募集资金的使 用与管理，提高募集资金使用效益，保护投资者的合法权益，根据《中华人民共 和国公司法》《中华人民共和国证券法》《首次公开发行股票注册管理办法》《上 市公司证券发行注册管理办法》《上市公司募集资金监管规则》及《上海证券交 易所股 ...